Purchases and Sales Made in Q2 2024 in Amylyx Pharmaceuticals, Inc. (AMLX)
This table provides information about the institutional ownership of Amylyx Pharmaceuticals, Inc. (AMLX) during Q2 2024. The information is specifically focused on institutions that hold shares of Amylyx Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 13, 2024
Q2 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-1.12M- 21.02% |
$1.82M - $3.05M
|
4.22M
$21M
|
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.15M- 55.35% |
$1.86M - $3.11M
|
924K
$4.59M
|
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.15M- 55.35% |
$1.86M - $3.11M
|
924K
$4.59M
|
|
|
Aug 13, 2024
Q2 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-1.8M- 40.34% |
$2.92M - $4.89M
|
2.67M
$13.2M
|
|
|
Aug 14, 2024
Q2 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-1.91M- 92.48% |
$3.09M - $5.16M
|
155K
$768K
|